TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 96 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $404,000 | +19.2% | 4,590 | +2.2% | 0.02% | +17.6% |
| Q3 2019 | $339,000 | +8.7% | 4,490 | +55.4% | 0.02% | -10.5% |
| Q1 2019 | $312,000 | -39.4% | 2,890 | -52.5% | 0.02% | -42.4% |
| Q4 2018 | $515,000 | +5.1% | 6,090 | +22.0% | 0.03% | +50.0% |
| Q3 2018 | $490,000 | -38.5% | 4,990 | -27.6% | 0.02% | -31.2% |
| Q2 2018 | $797,000 | -24.5% | 6,890 | -35.5% | 0.03% | -23.8% |
| Q1 2018 | $1,055,000 | +40.3% | 10,690 | +48.7% | 0.04% | +27.3% |
| Q4 2017 | $752,000 | -61.3% | 7,190 | -47.0% | 0.03% | -62.1% |
| Q1 2016 | $1,941,000 | +176.1% | 13,555 | +197.6% | 0.09% | +163.6% |
| Q4 2015 | $703,000 | -65.5% | 4,555 | -67.9% | 0.03% | -51.5% |
| Q2 2015 | $2,039,000 | +21.8% | 14,194 | +20.5% | 0.07% | +17.2% |
| Q1 2015 | $1,674,000 | +327.0% | 11,778 | +233.2% | 0.06% | +176.2% |
| Q1 2014 | $392,000 | – | 3,535 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |